Wikidata

(Q43140698)

English

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial

scientific article published on 7 March 2010

In more languages

Statements

title
Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
author name string
Preeta Kaur Narula
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
H S Rehan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
K E S Unni
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
Neeraj Gupta
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
publication date
7 March 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017
page(s)
218-223
1 reference
stated in
Europe PubMed Central
PubMed ID
20207521
retrieved
14 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43140698&oldid=2104995273"